Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07595003 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Efficacy, Safety, and Tolerability of 4-MUST, 128 mg Tablets in Chronic Cholecystitis and Biliary Dyskinesia

StatusRecruiting
PhasePhase 3
Started
View on ClinicalTrials.gov ↗

Record History

  1. Study First Submitted
The aim of the study is to evaluate the efficacy, safety, and tolerability of 4-MUST, 128 mg tablets compared to placebo in patients with chronic cholecystitis and biliary dyskinesia.
Trial Details
NCT Number NCT07595003
Lead Sponsor Valenta Pharm JSC
Conditions
(from sponsor)		 Chronic Cholecystitis, Biliary Dyskinesia
Related terms Biliary Dyskinesia
Enrollment 300 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov